Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1

18Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

125 FPKM) from TCGA database had a significantly reduced 5-year survival rate, and a lower 5-year survival rate in the chemotherapy and radiotherapy-treated patients (P

Cite

CITATION STYLE

APA

Zhang, P., Liu, J., Li, W., Li, S., & Han, X. (2018). Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1. Cancer Medicine, 7(7), 3178–3187. https://doi.org/10.1002/cam4.1529

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free